Axillary staging in women with small invasive breast tumours

European Journal of Surgical Oncology

Volumn 32, Issue 7, 2006, Pages 733-737

  della Rovere, G Q ^a   Bonomi, R ^a   Ashley, S ^a   Benson, J R ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Axillary management; Axillary recurrence; Axillary staging

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HOSPITAL POLICY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED;

EID: 33747794581     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.04.016     Document Type: Article

References (34)

1. Carter C.L., Allen C., and Henderson D.E. Relation of tumour size, lymph node status and survival in 24,740 breast cancer cases. Cancer 73 (1989) 505-508
2. Early Breast Cancer Trialists Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352 (1998) 930-942
3. Macmillan R.D., and Blamey R.W. The case for axillary sampling. Adv Breast Cancer 1 (2004) 9-10
4. Goyal A., and Mansel R.E. Sentinel lymph-node biopsy in breast cancer: facts and controversies. Adv Breast Cancer 1 (2004) 11-15
5. Mansel R. Sentinel node biopsy versus standard axillary treatment: results of the randomized multicenter UK ALMANAC Trial. Breast Cancer Res Treat 88 (2004) S13
6. Querci della Rovere G., and Benson J.R. The case for axillary dissection. Adv Breast Cancer 1 (2004) 3-8
7. Viale G., Bosari S., Mazzarol G., et al. Intra-operative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85 (1999) 2433-2439
8. Fisher B., Redmond C., Fisher E.R., et al. Ten year results of randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312 (1985) 674-681
9. McKinna F., Gothard L., Ashley S., Ebbs S., and Yarnold J. Selective avoidance of lymphatic radiotherapy in the conservative management of women with early breast cancer. Radiother Oncol 52 (1999) 219-223
10. Epstein R.J. Routine or delayed axillary dissection for primary breast cancer?. Eur J Cancer 31A (1995) 1570-1573
11. Greco M., Agresti R., Cascinella N., et al. Breast cancer patients treated without axillary surgery. Ann Surg 232 (2000) 1-7
12. Abner A.L., Collins L., Peiro G., and Recht A. Correlation of tumour size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Cancer 83 (1998) 2502-2508
13. Silverstein M., Gierson E., Waisman J., Senofsky G.M., Colburn W., and Gamagami P. Axillary lymph node dissection for T1a breast carcinoma: is it indicated?. Cancer 73 (1994) 664
14. Rosen P.P., Groshen S., Saigo P.E., Kinne D., and Hellman S. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N0M0) breast carcinomas: a study of 644 patients with median follow up of 18 years. J Clin Oncol 7 (1989) 1239-1251
15. Reger V., Beito G., and Jolly P.C. Factors affecting the incidence of incidence of lymph node metastases in small cancers of the breast. Am J Surg 157 (1989) 501-502
16. Steirer M., Rosen H.R., Weber R., Marczell A., Kornek G.V., and Czerwenka E. Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter. Surg Gynaecol Obstet 175 (1992) 151-160
17. Nemoto T., Vana J., Bedwani R.N., Baker H.W., McGregor F.H., and Murthy G.P. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45 (1980) 2917-2924
18. Bland K.I. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas (invited commentary). J Am Coll Surg 191 (2000) 6-8
19. Saiz E., Toonkel R., Poppiti R.J., and Robinson M.J. Infiltrating breast carcinoma smaller than 0.5 centimeters. Cancer 85 (1999) 2206-2211
20. Barth A., Craig P.H., and Silverstein M.J. Predictors of axillary lymph node metastases in patients with T1 breast carcinomas. Cancer 79 (1997) 1918-1922
21. Maibenco D.C., Weiss L.K., Pawlish K.S., and Severson R.F. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer 85 (1999) 1530-1536
22. Mustafa I., Bland K., and Chang H. Prognostic analysis of survival in small breast cancers. J Am Coll Surg 186 (1998) 562-563
23. Rivadeneira D.E., Simmons R., Christos P.J., Hanna K., Daly J.M., and Osborne M.P. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: Analysis of more than 900 patients. J Am Coll Surg 191 (2000) 1-6
24. www.adjuvantonline.com
25. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335 (1990) 1565-1568
26. Cady B. A contemporary view of axillary dissection (Editorial). Ann Surg 232 (2000) 8-9
27. Rietman J.S., Dijkastra P.U., Geertzen J.H., Baas P., de Vries J., and Dolsma W. Short-term morbidity of the upper limb after sentinel node biopsy or axillary lymph node dissection for stage I or 2 breast carcinoma. Cancer 98 (2003) 690-696
28. Sener S.F., Winchester D.J., Martz C.H., et al. Lymphoedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92 (2001) 748-752
29. Julian T.B., Krag D., Brown A., et al. Preliminary technical results of NSABP B32, a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node negative breast cancer patients. Breast Cancer Res Treat Suppl. 1 (2004) 83 Abstract 14 S11
30. Kissin M.W., Querci della Rovere G., Easton D., and Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73 (1986) 580-584
31. Querci della Rovere G., Ahmad I., Singh P., Ashley S., Daniels I.R., and Mortimer P. An audit of the incidence of arm lymphoedema after prophylactic lever I/II axillary dissection without division of the pectoralis minor muscle. Ann R Coll Surg Engl 85 (2003) 158-161
32. Cabanes P.A., Salamon R.J., Vilcoq J.R., et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339 (1992) 1245-1248
33. White R.E., Vezeridis M.P., Konstadoulakis M., et al. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 183 (1996) 575-582
34. Querci della Rovere G., and Benson J.R. The biological significance of ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis. Lancet Oncol 3 (2002) 45-49